Healthcare resources and costs associated with nonvalvular atrial fibrillation in Spain: apixaban versus acenocoumarol

Aim: Healthcare resources usage and costs associated to nonvalvular atrial fibrillation (NVAF) were analyzed in Spain. Methods: This is an observational and retrospective study on patients with NVAF who started their treatment with apixaban or acenocoumarol between 1 January 2015 and 31 December 2...

Full description

Bibliographic Details
Main Authors: Josep Comin Colet, Antoni Sicras Mainar, Joel Salazar-Mendiguchia, Isabel del Campo Alonso, Ainara Echeto, David Vilanova Larena, Olga Delgado Sanchez
Format: Article
Language:English
Published: Becaris Publishing Limited 2023-07-01
Series:Journal of Comparative Effectiveness Research
Subjects: